Skip to main content
ISTH 2023 Main banner
Back

    Sven Danckwardt, MD (he/him/his)

    Univ.-Prof. Dr. med.
    Center for Thrombosis and Hemostasis (CTH), University Medical Centre Mainz, Germany
    Mainz, Rheinland-Pfalz, Germany

    After his medical studies in Tübingen, Berlin and San Diego, USA, Sven Danckwardt received training in pediatric oncology and hematology and became a postdoctoral fellow and senior physician scientist at the European Molecular Biology Laboratory (EMBL) MMPU (with Andreas Kulozik and Matthias Hentze). In 2011 he obtained the habilitation from the Ruprecht-Karls University in Heidelberg and joined the Medical Faculty, MLU Halle as independent group leader (on RNA and tumor cell biology). In 2011, Sven Danckwardt received the Hella Bühler Award for Cancer Research and a call for a group leader position at the Medical Research Council (MRC) Human Genetics Unit at the University of Edinburgh, UK. Since 2013 he has been working at the University Medical Center Mainz at the Center for Thrombosis and Hemostasis (CTH) and Institute for Clinical Chemistry as Professor for Experimental Hemostasis and Laboratory Medicine.

    His research interests include the role of coagulation factors in processes beyond blood coagulation, miRNA and RBP-mediated control of the hemostatic system, mechanisms and consequences of transcriptome perturbations, and non-invasive molecular imaging. Sven Danckwardt is co-chair of the ISTH SSC Genomics in Thrombosis and Hemostasis, PI in the EU Horizon 2020 ITN programm 'Thrombo-inflammation in cardiovascular disease' (TICARDIO) and the German Center for Cardiovascular Research (DZHK). His laboratory has published the Atlas of the hemostatic miRNA targetome and is developing novel tools and genetic resources for non-invasive monitoring of secretory proteins in living organisms https://www.biorxiv.org/content/10.1101/2021.07.08.451623v7.full

    Presentation(s):